http://www.unboundmedicine.com/medline/ebm/research/muromonab_CD3Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19805910/full_citation/Adoptive_immunotherapy_with_liver_allograft_derived_lymphocytes_induces_anti_HCV_activity_after_liver_transplantation_in_humans_and_humanized_mice_Ohira M, Ishiyama K, Tanaka Y, et al. 
Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice. [Journal Article, Research Support, Non-U.S. Gov't]
J Clin Invest 2009 Nov; 119(11):3226-35.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19758190/full_citation/Preventing_viral_induced_type_1_diabetes_Richer MJ, Horwitz MS 
Preventing viral-induced type 1 diabetes. [Journal Article, Research Support, Non-U.S. Gov't]
Ann N Y Acad Sci 2009 Sep.:487-92.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19638292/full_citation/Characterization_of_natural_killer__NK__and_natural_killer_like_T__NKT__cells_derived_from_ex_vivo_expanded_and_activated_cord_blood_mononuclear_cells:_Implications_for_adoptive_cellular_immunotherapy__ACI__Ayello J, van de Ven C, Cairo E, et al. 
Characterization of natural killer (NK) and natural killer-like T (NKT) cells derived from ex-vivo expanded and activated cord blood mononuclear cells: Implications for adoptive cellular immunotherapy (ACI). [JOURNAL ARTICLE]
Exp Hematol 2009 Jul 25.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19561539/full_citation/Construction_and_Preclinical_Evaluation_of_an_Anti_CD19_Chimeric_Antigen_Receptor_Kochenderfer JN, Feldman SA, Zhao Y, et al. 
Construction and Preclinical Evaluation of an Anti-CD19 Chimeric Antigen Receptor. [JOURNAL ARTICLE]
J Immunother 2009 Jun 24.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19443276/full_citation/Treatment_of_patients_with_new_onset_Type_1_diabetes_with_a_single_course_of_anti_CD3_mAb_teplizumab_preserves_insulin_production_for_up_to_5_years_Herold KC, Gitelman S, Greenbaum C, et al. 
Treatment of patients with new onset Type 1 diabetes with a single course of anti-CD3 mAb teplizumab preserves insulin production for up to 5 years. [JOURNAL ARTICLE]
Clin Immunol 2009 May 12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19409176/full_citation/[CD3_specific_antibody_induced_T_cell_apoptosis_and_apoptotic_cell_uptake_lead_to_CD3_specific_antibody_induced_tolerance]Perruche S, Saas P 
[CD3-specific antibody-induced T-cell apoptosis and apoptotic cell uptake lead to CD3-specific antibody-induced tolerance] [News]
Med Sci (Paris) 2009 Apr; 25(4):325-7.
Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19348913/full_citation/Therapeutic_approaches_to_allergy_and_autoimmunity_based_on_FoxP3+_regulatory_T_cell_activation_and_expansion_Miyara M, Wing K, Sakaguchi S 
Therapeutic approaches to allergy and autoimmunity based on FoxP3+ regulatory T-cell activation and expansion. [Journal Article, Research Support, Non-U.S. Gov't, Review]
J Allergy Clin Immunol 2009 Apr; 123(4):749-55; quiz 756-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19340342/full_citation/Canadian_Cardiovascular_Society_Consensus_Conference_update_on_cardiac_transplantation_2008:_Executive_Summary_Haddad H, Isaac D, Legare JF, et al. 
Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary. [Journal Article]
Can J Cardiol 2009 Apr; 25(4):197-205.
Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19259792/full_citation/Cell_type_specific_targeting_with_surface_engineered_lentiviral_vectors_co_displaying_OKT3_antibody_and_fusogenic_molecule_Yang H, Joo KI, Ziegler L, et al. 
Cell type-specific targeting with surface-engineered lentiviral vectors co-displaying OKT3 antibody and fusogenic molecule. [Journal Article, Research Support, N.I.H., Extramural]
Pharm Res 2009 Jun; 26(6):1432-45.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19202453/full_citation/Human_anti_mouse_antibodies_interferences_in_Elecsys_PTH_assay_after_OKT3_treatment_Cavalier E, Carlisi A, Chapelle JP, et al. 
Human anti-mouse antibodies interferences in Elecsys PTH assay after OKT3 treatment. [Letter]
Transplantation 2009 Feb 15; 87(3):451-2.
Full Citation | Publisher Full Text | Find Related Articles